1. Rapid Uptake and Photodynamic Inactivation of Staphylococci by Ga(III)-Protoporphyrin IX
- Author
-
Ana V. Morales-de-Echegaray, Naveen Reddy Kadasala, Alexander Wei, Mohamed N. Seleem, Waleed Younis, Thora R. Maltais, and Lu Lin
- Subjects
Keratinocytes ,Methicillin-Resistant Staphylococcus aureus ,0301 basic medicine ,Staphylococcus aureus ,medicine.medical_treatment ,030106 microbiology ,Protoporphyrins ,Gallium ,Photodynamic therapy ,Heme ,medicine.disease_cause ,Staphylococcal infections ,Fluorescence ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,medicine ,Humans ,Photosensitizer ,Cytotoxicity ,Microbial Viability ,Photosensitizing Agents ,Protoporphyrin IX ,Chemistry ,Antimicrobial ,medicine.disease ,Molecular biology ,HEK293 Cells ,030104 developmental biology ,Infectious Diseases ,Photochemotherapy ,Hemin - Abstract
Antimicrobial photodynamic therapy (aPDT) is a promising method for the topical treatment of drug-resistant staphylococcal infections, and can be further improved by identifying mechanisms that increase the specificity of photosensitizer uptake by bacteria. Here we show that Ga(III)-protoporphyrin IX chloride (Ga-PpIX), a fluorescent hemin analog with previously undisclosed photosensitizing properties, can be taken up within seconds by Staphylococcus aureus including multidrug-resistant strains such as MRSA. The uptake of Ga-PpIX by staphylococci is likely diffusion-limited and is attributed to the expression of high-affinity cell-surface hemin receptors (CSHRs), namely iron-regulated surface determinant (Isd) proteins. A structure–activity study reveals the ionic character of both the heme center and propionyl groups to be important for uptake specificity. Ga-PpIX was evaluated as a photosensitizer against S. aureus and several clinical isolates of MRSA using a visible light source, with antimicrobial activity (3-log reduction in CFU/mL) at 0.03 μM with 10 seconds of irradiation by a 405-nm diode array (1.4 J/cm(2)); antimicrobial activity could also be achieved within minutes using a compact fluorescent lightbulb. GaPpIX was many times more potent than PpIX, a standard photosensitizer featured in clinical aPDI, but also demonstrated low cytotoxicity against HEK293 cells and human keratinocytes. Ga-PpIX uptake was screened against a diverse panel of bacterial pathogens using a fluorescence-based imaging assay, which revealed rapid uptake by several Gram-positive species known to express CSHRs, suggesting future candidates for targeted aPDT.
- Published
- 2018
- Full Text
- View/download PDF